Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...

Brookstone Capital Management lifted its holdings in KeyCorp (NYSE:KEY – Free Report) by 6.3% in the fourth quarter, ...

The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.

Most Asian stocks rose on Monday after major U.S. stock indexes rallied to close out their best week in two months Friday on ...

Reach, which owns the Daily Mirror, Express and Daily Star newspapers and a raft of regional titles, said trading in the fourth quarter of 2024 was 'strong'.

The People's Bank of China has announced that it would leave key interest rates unchanged. Following a meeting of the Monetary Policy Committee, a decision was made by the central bank to maintain its ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...

President-elect Donald Trump could take action in two key areas: restricting foreign organizations receiving U.S. funding ...

The current price of Dai (DAI) is $0.999982, as of January 18, 2025. Over the last 24 hours, the price has moved by -0.01%, with a change of 0.02% in the past hour. For longer-term performance, the ...